Aviva Holdings Ltd.

Q3 2017 13F Combination Report, Stock Holdings

Signature - Title
Paul Higgs - Director
Location
Lyford Cay, New Providence, Bahamas
Holdings as of
September 30, 2017
Value $
$192M
Num holdings
4
Date filed
11/14/2017, 04:25 PM
Description
A portion of the US holdings for this investor are reported in this report and a portion are reported by other reporting manager(s). Confidential Treatment Requested (one or more holding(s) omitted). The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q2 2017 - Aug 14, 2017
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2017 Q3 compared to 2017 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Confidential Treatment Requested. (The Manager has omitted from this public Form 13F one or more holding(s) for which it is requesting confidential treatment from the U.S. Securities and Exchange Commission pursuant to section 13(f) of the Exchange Act and rule 24b-2 thereunder)

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Jason C. Callender Director Nassau, Bahamas 11/14/2017

Information with respect to which the Institutional Investment Manager is requesting Confidential Treatment has been omitted and filed separately with the Securities and Exchange Commission.

Other Included Managers (1):

Num Name Location File Number
1 Braslyn Ltd. 028-17341